LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 14, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
25,418
Total Value
$1,779,474.40
P&L
+inf% (+$3,312,691.62)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO & Secretary | Common Stock | โ | Feb 14, 2026 | Grant/Award | 6,928 | $0.00 | $0.00 | 37,739 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Feb 14, 2026 | Tax Withholding | 3,211 | $183.83 | $590,278.13 | 34,528 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Feb 14, 2026 | Grant/Award | 8,810 | $0.00 | $0.00 | 43,338 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Feb 14, 2026 | Tax Withholding | 4,083 | $183.83 | $750,577.89 | 39,255 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Feb 15, 2026 | Tax Withholding | 593 | $183.83 | $109,011.19 | 38,662 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Feb 15, 2026 | Tax Withholding | 801 | $183.83 | $147,247.83 | 37,861 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Feb 15, 2026 | Tax Withholding | 992 | $183.83 | $182,359.36 | 36,869 | Direct | โ | View Details |